Autonomix Medical (NASDAQ:AMIX) Trading Down 2.6% – Should You Sell?

Autonomix Medical, Inc. (NASDAQ:AMIX) fell 2.6% during trading on Tuesday . The stock traded as low as $0.3717 and last traded at $0.3799. 81,555 shares were traded during mid-day trading, a decline of 37% from the average session volume of 129,174 shares. The stock had previously closed at $0.39.

Wall Street Analysts Forecast Growth

Several research firms have commented on AMIX. Weiss Ratings restated a “sell (e+)” rating on shares of Autonomix Medical in a research note on Wednesday, January 21st. Maxim Group cut their target price on Autonomix Medical from $5.00 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $2.00.

Autonomix Medical Trading Down 2.6%

The stock has a market cap of $2.63 million, a P/E ratio of -0.11 and a beta of -2.48. The company has a 50 day simple moving average of $0.40 and a 200 day simple moving average of $0.69.

Autonomix Medical (NASDAQ:AMIX) last posted its quarterly earnings results on Wednesday, February 11th. The company reported ($0.36) earnings per share for the quarter, topping the consensus estimate of ($0.46) by $0.10. As a group, sell-side analysts expect that Autonomix Medical, Inc. will post -10 earnings per share for the current year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.